- ￥1668
- abinScience
- China
- HB738033
- 2026年03月03日
- ELISA, FCM
- Human
- Human
企业认证
相关产品推荐更多 >
Anti-Human ZBTB7B Antibody (C206), 抗人ZBTB7B抗体 (C206)
￥1176
Anti-LASV GPC Antibody (10.4B), 抗LASVGPC抗体 (10.4B)
￥1338
Anti-Influenza A Virus H7 subtype Hemagglutinin/HA Antibody (07-4B03), 抗InfluenzaA Virus H7 subtype Hemagglutinin/HA抗体 (07-4B03)
￥1668
Research Grade Anti-Human CD19 (JCAR014), 研究级Anti-Human CD19 (JCAR014)
￥2588Anti-Agrobacterium sp. aroA/EPSPS Monoclonal Antibody (1A078), 抗Agrobacteriumsp. aroA/EPSPS Monoclonal抗体 (1A078)
￥1168
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
HB738033
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 应用范围：
ELISA, FCM
- 浓度：
1mg/mL
- 靶点：
Ephrin type-A receptor 2, EC:2.7.10.1, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK, EPHA2
- 抗体英文名：
Anti-Human EPHA2 Antibody (SAA2280)
- 抗体名：
Anti-Human EPHA2 Antibody (SAA2280)
- 规格：
100ul
| Product name | Anti-Human EPHA2 Antibody (SAA2280) |
|---|---|
| Catalog No. | HB738033 |
| Host species | Human |
| Species reactivity | Human |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >90% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, FCM |
| Target | Ephrin type-A receptor 2, EC:2.7.10.1, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK, EPHA2 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | P29317 |
| Alternative Names | / |
| Clone ID | SAA2280 |
| Species | / |
| Product Usage Information | / |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• Oncogenic functions and therapeutic targeting of EphA2 in cancer., PMID:33686241
• Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer., PMID:37924938
• Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma., PMID:35227773
• Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein-Barr virus entry into epithelial cells., PMID:38649412
• Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide., PMID:39239524
• Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2., PMID:39346536
• EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma., PMID:35105853
• Targeting the EphA2 pathway: could it be the way for bone sarcomas?, PMID:39252029
• Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)., PMID:39259047
上海西唐生物科技有限公司 021-55229872, 65333639 www.westang.com 人血清淀粉样蛋白 (SAA)ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 SAA 单抗包被于酶标板上，标准品和样品中的 SAA与单抗结合，加入生物素化的抗人 SAA ，形成
技术资料暂无技术资料 索取技术资料
